Skip to main content
OpenTrials

Clinical trial condition

RNA Virus Infections

Explore clinical trials studying RNA Virus Infections. Study availability and eligibility vary by location and protocol.

15,801 public trials 834 recruiting studies
Refine in advanced search Browse all conditions

RNA Virus Infections trial results

Completed

Pre-exposure Prophylaxis (PrEP) at Home

NCT03569813

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • Emory University, PRISM Health Atlanta, Georgia, United States
  • The Fenway Institute Boston, Massachusetts, United States
  • Open Arms Health Care Center Jackson, Mississippi, United States
  • Washington University AIDS Clinical Trial Unit St Louis, Missouri, United States
View Trial Details
Completed

Genotype-Informed Versus Empiric Management of VirEmia

NCT04233242

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • Seboche Mission Hospital Seboche, Butha-Buthe, Lesotho
  • Baylor Clinic Leribe Hlotse, Leribe District, Lesotho
  • Baylor Clinic Butha-Buthe Butha-Buthe, Lesotho
  • Baylor Clinic Maseru Maseru, Lesotho
View Trial Details
Completed

A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone or Co-administered With an Adjuvanted Vaccine Against Influenza in Adults Aged 65 Years and Above

NCT05568797

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • GSK Investigational Site Edegem, Belgium
  • GSK Investigational Site Erpent, Belgium
  • GSK Investigational Site Genk, Belgium
  • GSK Investigational Site Ieper, Belgium
View all 37 locations
View Trial Details
Completed

A Study on the Immune Response and Safety Elicited by a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Influenza in Adults Aged 65 Years and Above

NCT05559476

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Tempe, Arizona, United States
  • GSK Investigational Site Canoga Park, California, United States
  • GSK Investigational Site Colton, California, United States
View all 46 locations
View Trial Details

Related conditions